DONSON

ncRNA information

ncRNA name

DONSON

Specific or universal ncRNAs

Specific ncRNAs

Class

Circular RNA

Biomarker

None

Biomarker application

Upstream regulatory factors

Not available

Downstream target

miR-802/BMI1

Cancer information

Cancer name

Gastric Cancer

Cancer site

qRT-PCR,Western blot,Dual-luciferase assay

Treatment information

Treatment type

Chemotherapy

Drug

Cisplatin

Impact of wild-type ncRNA on chemotherapy resistance

Up

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

34

Male patients

26

Female patients

32(<50)+28(>=50)

Age range and number

Not available

Research information

PMID

Description

CircRNA DONSON contributes to cisplatin resistance in gastric cancer cells by regulating miR-802/BMI1 axis

Tissue resource

human gastric cancer cell lines AGS

human gastric cancer cell lines HGC-27

normal gastric mucosa from noncancerous patients and gastric cancer tissues

human gastric epithelial immortalized cell lines GES-1

Experiment

60


Institute

Third Affiliated Hospital of Soochow University

Beijing Institute for Cancer Research Collection

Country

China

China

Continent

Asia

Asia